AIXC - AIxCrypto Holdings,... Stock Analysis | Stock Taper
Logo
AIxCrypto Holdings, Inc.

AIXC

AIxCrypto Holdings, Inc. NASDAQ
$1.38 7.81% (+0.10)

Market Cap $7.12 M
52w High $8.81
52w Low $0.92
P/E -0.16
Volume 69.29K
Outstanding Shares 5.16M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $0 $7.36M $-10.6M 0% $-3.76 $-10.24M
Q3-2025 $0 $1.43M $-2.04M 0% $-4.68 $-1.58M
Q2-2025 $0 $1.68M $-1.69M 0% $-1 $-1.58M
Q1-2025 $0 $2.72M $-2.65M 0% $-1.82 $-2.57M
Q4-2024 $0 $1.33M $-855.82K 0% $0 $-749.82K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $19.33M $31.28M $3.33M $27.95M
Q3-2025 $38.78M $43.47M $4.92M $38.55M
Q2-2025 $331.6K $3.96M $5.61M $-1.65M
Q1-2025 $30.21K $2.85M $2.81M $33.13K
Q4-2024 $1.17M $4.69M $2.01M $2.68M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-10.6M $-2.12M $-14.07M $-3.25M $-19.44M $-2.12M
Q3-2025 $-2.04M $-2.14M $-291K $40.88M $38.45M $-2.14M
Q2-2025 $-1.69M $-1.1M $-1.21M $2.61M $301.39K $-1.1M
Q1-2025 $-2.65M $-1.59M $-305K $750K $-1.14M $-1.59M
Q4-2024 $-855.82K $-2.27M $-1.01M $4.06M $786.46K $-2.27M

5-Year Trend Analysis

A comprehensive look at AIxCrypto Holdings, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

AIxCrypto’s main strengths are its strong near‑term liquidity, minimal reliance on debt, and a bold, clearly articulated vision at the intersection of AI, blockchain, and real‑world assets. The strategic backing from Faraday Future provides both validation and an immediate application domain for its technology. The AIxC Hub’s rapid user‑wallet growth indicates early ecosystem traction, and the company’s explicit focus on regulatory compliance could help differentiate it in a space often viewed as risky and unregulated.

! Risks

The most significant risks are financial and execution‑related. The company currently has no revenue and sizable operating losses, burning cash from operations and investments and relying heavily on equity markets for funding. A long history of accumulated losses underscores this pattern. Strategically, the firm is undergoing a major pivot from biotech to AI and Web3, which brings integration and focus risks. It also operates in highly competitive and fast‑evolving markets, under uncertain regulatory frameworks, where many well‑funded players are pursuing similar ideas. Failure to convert a large, mostly free user base into paying customers would leave the business model unproven.

Outlook

Near‑term, the outlook is dominated by continued investment, cash burn, and the need for further external funding unless revenue ramps meaningfully. Over the medium term, the company’s prospects depend on whether it can turn its EAI and RWA platforms into commercially adopted products, deepen its partnership ecosystem, and scale its user base into a monetizable network. If execution on the technology and regulatory fronts is successful, the platform could benefit from strong network effects; if not, the combination of high competition and ongoing losses could become increasingly challenging. Overall, uncertainty is high, with considerable upside potential but equally significant operational and financial risk.